RxDoctor Payments Data

Dennis Thomas

Cardiovascular Disease · Mobile, ALNPI 1831344217

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $891,272 of the $893,522 with a category attached, or 99.7%. 3 manufacturers reported payments, led by Kedplasma LLC at 44.2% of the total. Among cardiovascular disease clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$893,522in general payments, 2019–2025

Across 528 payments — averaging $1692.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kedplasma LLC$395K
  • CSL Plasma Inc.$325K
  • CSL Behring$174K

What the payments were for

  • Consulting fees$891,272100%
  • Travel & lodging$2,2500%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Kedplasma LLC172$394,501
CSL Plasma Inc.217$324,669
CSL Behring139$174,353

How this compares

$893,522 in reported general payments places this provider in the 95th percentile of 292 cardiovascular disease providers in Alabama.

See all cardiovascular disease providers in Alabama

Other cardiovascular disease in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →